0001140361-22-002187.txt : 20220120 0001140361-22-002187.hdr.sgml : 20220120 20220120160534 ACCESSION NUMBER: 0001140361-22-002187 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220119 FILED AS OF DATE: 20220120 DATE AS OF CHANGE: 20220120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOOD LAUREN CENTRAL INDEX KEY: 0001769757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 22542370 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 4 1 form4.xml FORM 4 X0306 4 2022-01-19 0001472091 PDS Biotechnology Corp PDSB 0001769757 WOOD LAUREN C/O PDS BIOTECHNOLOGY CORPORATION 25B VREELAND ROAD, SUITE 300 FLORHAM PARK NJ 07932 true Chief Medical Officer Employee Stock Option (Right to Buy) 6.28 2022-01-19 4 A 0 88600 0 A 2032-01-19 Common Stock 88600 88600 D This option, representing a right to purchase a total of 88,600 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026. /s/ Hillary Yegen, attorney-in-fact 2022-01-20